smi infographics blz 5g 2018.04 · 2018-04-03 · activity flowchart total data collected censuses...

2
Salud Mesoamérica regions Belize performance indicators Success stories BELIZE Baseline 1 st follow-up 4095 Oxytocin/ uterotonic administration following delivery 4103 Immediate postpartum check for neonate Intervention BASELINE (2013) 1 ST FOLLOW-UP (2014) 2500 3040 4030 4070 4080 4095 4103 4410 * Study design 100 80 60 40 20 0 1 3 Facilities Women Children Facilities 39 38 351 311 *new indicator, not measured at baseline or 1 st follow-up 2500 family planning after delivery, 3040 ANC visit <= 12 weeks, 4030 Postpartum care <=7 days, 4070 Management of neonatal complications, 4080 Management of maternal complications, 4095 Oxytocin/ uterotonic administration after delivery, 4103 Immediate PPC for neonates, 4410 Growth and development checks, 4420 Child enrollment <=7 days after birth, 5135 Management of diarrhea Source: SMI Medical Record Review in health facilities 2 nd follow-up % of medical records that meet the indicator 4420 5135 2 2 ND FOLLOW-UP (2017) Facilities Women Children 20 434 480 www.healthdata.org/salud-mesoamerica-initiative 1 st follow-up 2 nd follow-up 80.0% 98.7% 0% of medical records in facility met indicator 100% of medical records in facility met indicator Pulse Apgar score (at 1 or 5 minutes) Respiratory rate Weight Height/length Oxytetracycline ophthalmic prophylaxis or chloramphenicol administration Vitamin K administration Indicator total 1 2 3 4 5 6 7 8 1 st follow-up 2 nd follow-up Baseline 1 2 3 4 5 6 7 8

Upload: others

Post on 13-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: SMI infographics BLZ 5G 2018.04 · 2018-04-03 · Activity flowchart Total data collected Censuses Households Women Children Students Health facilities Medical records 90,533 74,200

SaludMesoaméricaregions

Belize performance indicators

Success stories

BELIZEBaseline 1st follow-up

4095 Oxytocin/ uterotonic administration following delivery

4103 Immediate postpartum check for neonate

Intervention

BASELINE(2013)

1ST FOLLOW-UP(2014)

2500 3040 4030 4070 4080 4095 4103 4410*

Study design

100

80

60

40

20

0

1 3

Facilities Women Children Facilities

39 38351 311

*new indicator, not measured at baseline or 1st follow-up

2500 family planning after delivery, 3040 ANC visit <= 12 weeks, 4030 Postpartum care <=7 days, 4070 Management of neonatal complications, 4080 Management of maternal complications, 4095 Oxytocin/ uterotonic administration after delivery, 4103 Immediate PPC for neonates, 4410 Growth and development checks, 4420 Child enrollment <=7 days after birth, 5135 Management of diarrhea

Source: SMI Medical Record Review in health facilities

2nd follow-up

% o

f med

ical

reco

rds t

hat m

eet t

he in

dica

tor

4420 5135

2

2ND FOLLOW-UP(2017)

Facilities Women Children

20 434 480

www.healthdata.org/salud-mesoamerica-initiative

1st follow-up

2nd follow-up

80.0%

98.7%

0% of medical records in facility met indicator100% of medical records in facility met indicator

Pulse

Apgar score (at 1 or 5 minutes)

Respiratory rate

Weight

Height/length

Oxytetracycline ophthalmic prophylaxis or chloramphenicol administration

Vitamin K administration

Indicator total

1

2

3

4

5

6

7

8

1st follow-up 2nd follow-upBaseline1

2

3

4

5

6

7

8

Page 2: SMI infographics BLZ 5G 2018.04 · 2018-04-03 · Activity flowchart Total data collected Censuses Households Women Children Students Health facilities Medical records 90,533 74,200

Activity flowchart Total data collected

Censuses

Households

Women

Children

Students

Health facilities

Medical records

90,533 74,20020,225 12,70924,614 16,71523,005 14,080

924 1,500

Baseline 2nd follow-up*

479 379 481Baseline 2nd follow-up*1st follow-up

9,929 12,662

Study and survey design

Data collection (in-country agencies)

Analysis and dissemination

• Fact-finding visits• Instrument design• Trainings and pilots• Sampling

• Community census• Household survey• Health facility survey• School survey• Real-time data

quality checks

• Estimation of SMI performance and monitoring indicators

• Assessment of country compliance with predetermined SMI indicator targets

• In-depth review of indicator components and drivers

• Process and impact evaluation• Publication of findings in

peer-reviewed journals

Health facility surveys

Household and school surveys

14,146

*2nd follow-up data collection completed in 4 of 8 countries; sample sizes are estimates

In Mesoamerica, the region consisting of southern Mexico and Central America, the results-based aid project known as the Salud Mesoamérica Initiative (SMI) was designed to reduce disparities in maternal and child health, focusing on the poorest 20% of the population across the region.

The Inter-American Development Bank (IDB) provides extensive technical support to countries to implement transformative solutions by expanding coverage as well as increasing the quality and use of basic public health services in the areas of reproductive, maternal, neonatal and child health care. IHME works closely with IDB to collect and analyze data to verify results and assess the impact of SMI. The performance indicators and targets were set with governments, in line with country-specific priorities in maternal and child health. Key indicators include coverage of contraceptives, antenatal and postnatal care for women and newborns, in-facility delivery and skilled birth attendance, management of obstetric and neonatal complications, complete vaccination coverage for age, prevalence of anemia in children, and quality of care for health facility visits.

Baseline and first follow-up measurements in SMI’s eight participating countries are now complete. At the first follow-up measurement, all countries showed progress in performance indicators, with areas for improvement. El Salvador, Honduras, Nicaragua, Panama, and Costa Rica reached their first follow-up targets, while the State of Chiapas in Mexico, Guatemala, and Belize did not. A performance improvement plan measurement in Chiapas and Guatemala showed continued progress, as previously-missed targets were achieved nine to 12 months later.

The second follow-up evaluation is under way, with data collection already complete in four countries. Honduras, El Salvador, Nicaragua, and Belize reached their second follow-up targets. Indicators for timely antenatal care, antenatal care with quality, in-facility delivery, management of neonatal and obstetric complications, diarrhea management, and micronutrient consumption showed promising results, while indicators for postpartum care, anemia reduction, and deworming treatment still need more work. Data collection activities in 2018 are planned for Chiapas, Panama, Guatemala, and Costa Rica.

2011 2012 2013 2014 2015 2016 2017 2018

1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4

Year

Quarter

Methods and instrument development

Data collection

Report generation and analysis

Evaluation round

Type of data collected

Baseline measurement

First follow-up measurement

Performance Improvement Plan

Process Evaluation

Second follow-up measurement

1 2 3 4 5

?

Health fa

cilitie

s

Focus g

roups

Schools

Interviews

Households

SMI evaluation timeline of key activities